Tesamorelin acetate bulk supplier for pharma manufacturers

Tesamorelin Acetate 1mg, 2mg Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 1mg, 2mg

Reference Brands: Egrifta (USA)

Tesamorelin acetate is a synthetic analogue of human growth hormone-releasing factor (GRF) that stimulates the pituitary gland to release endogenous growth hormone. It is primarily used for reducing excess visceral abdominal fat in HIV-infected patients with lipodystrophy. The drug improves body composition without significantly affecting subcutaneous fat.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Tesamorelin Acetate — third party manufacturing & bulk supply

Tesamorelin Acetate 1mg, 2mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Tesamorelin Acetate is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Tesamorelin Acetate listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Tesamorelin Acetate →

Back to Listing

Frequently Asked Questions

Tesamorelin acetate is listed as Injection in 1mg, 2mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Tesamorelin acetate is referenced against Egrifta (USA). Reference brands are shown for identification only and remain the property of their respective trademark owners.